 vivo administration recombinant granulocyte-macrophage colony-stimulating factor results reversible inhibition primary lymphopoiesis vivo administration granulocyte-macrophage CSF GM-CSF production lymphocytes bone marrow mice cytokine kinetics cell production wk GM-CSF treatment number cell progenitors Ag IgM cells detectable cellularity spleen two-fold due part increase number granulocyte-macrophage progenitor cells splenic cell levels GM-CSF treatment numbers marrow cells immediate progenitors due treatment cells capable lymphopoiesis present tissue cessation GM-CSF treatment lymphopoiesis marrow mice supernormal levels wk last GM-CSF injection effect due actions GM-CSF lymphopoietic support capability marrow environment overproduction cells marrow GM-CSF donors severe immunodeficient mice